Swiss National Bank Opti Nose, Inc. Transaction History

Swiss National Bank

  • $146 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 05, 2020
SELL
$3.58 - $7.44 $157,162 - $326,616
-43,900 Closed
0 $0
Q4 2019

Feb 06, 2020
BUY
$6.27 - $11.41 $82,764 - $150,612
13,200 Added 43.0%
43,900 $405,000
Q2 2019

Aug 02, 2019
BUY
$6.4 - $10.94 $52,480 - $89,708
8,200 Added 36.44%
30,700 $217,000
Q1 2019

May 10, 2019
BUY
$6.1 - $10.3 $16,470 - $27,810
2,700 Added 13.64%
22,500 $232,000
Q2 2018

Aug 09, 2018
BUY
$18.75 - $28.46 $371,250 - $563,508
19,800 New
19,800 $554,000

Others Institutions Holding OPTN

# of Institutions
2
Shares Held
5.29M
Call Options Held
0
Put Options Held
0
View Full List

About OptiNose, Inc.

OPTN Quotes by TradingView
  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $500M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email